Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Bilbao Vizcaya Argentaria SA vs Enveric Biosciences Inc — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $25.35 (market cap $141.17B), while Enveric Biosciences Inc trades at $1.25 (market cap $5.36M). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 26337.7× Enveric Biosciences Inc's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 4.25% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| BBVA | ENVB | |
|---|---|---|
Market Cap | $141.17B | $5.36M |
Sector | Financials | Health |
52-Week High | $26.14 | $17.40 |
52-Week Low | $14.73 | $1.28 |
Dividend Yield | 4.25% | — |
Enterprise Value | — | $449.11K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
